The Boiron Way At Boiron, we believe there’s more than one way to feel better — a way that works with your body, not against it. We encourage you to choose wellness by choosing us. And we honor your choice with medicines made from Earth’s best resources. In 1932, twin brothers and pharmacists Jean and Henri Boiron set out to develop a way to prepare reliable homeopathic medicines for their patients. Today, as world leader in homeopathic medicines, Boiron continues as an independent pharmaceutical laboratory that prides itself on quality manufacturing and responsible environmental practices. It’s still operated by the Boiron family who continues to be passionate about integrating the benefits of homeopathic medicine into daily life. Oscillococcinum Pellets The moment you feel achy or rundown, nip flu-like symptoms in the bud with Boiron Oscillococcinum. Clinical studies show that Oscillococcinum reduces the duration and severity of flu symptoms such as body aches, headache, fever, chills and fatigue.* 1-2 Easy to take, the slightly sweet pellets dissolve under the tongue and are recommended for everyone ages 2 and up. This homeopathic flu medicine is used in more than 50 countries, including France for more than 50 years and where it is currently the overall best-selling flu medicine. It’s non-drowsy and does not interact with other medications or supplements. It won’t mask symptoms of a more serious condition. Oscillococcinum is available over the counter in boxes of 6, 12, or 30 doses. Boiron’s also offers its ColdCalm line, Chestal cough syrup line, ThroatCalm and Sinusalia. (Oscillo.com) *These “Uses” have not been evaluated by the Food and Drug Administration. Papp R, Schuback G, Beck E, et al. Oscillococcinum(R) in patients with influenza-like syndromes: a placebo-controlled double-blind evaluation. British Homoeopathic Journal. 1998;87(2):69-76. doi:10.1038/sj.bhj.5800208. Ferley JP, Zmirou D, D'Adhemar D, Balducci F. A controlled evaluation of a homoeopathic preparation in the treatment of influenza-like syndromes. British Journal of Clinical Pharmacology. 1989;27(3):329-335. doi:10.1111/j.1365-2125.1989.tb05373.x.